eprotirome
Phase 3- Indications
- Heterozygous familial hypercholesterolemia, Dyslipidemia
Company intelligence / Profile preview
Karo Healthcare AB
Huddinge, Stockholm region, Swedenkarohealthcare.com ↗
- Ownership
- Private
- Employees
- ~70
- Development stage
- Phase 3
01
Overview
The company has evolved from a drug discovery company to a commercial healthcare company with a portfolio of branded medicines across various healthcare categories.
- Therapeutic areas
- CardiovascularPsychiatryMetabolic DisordersImmunologyWomen's HealthOncology
- Modalities
- Small molecules
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
Abbott LaboratoriesBristol-Myers SquibbMerck & Co. Inc.Bayer AGAres-SeronoMillennium Pharmaceuticals Inc.Novartis Research Foundation
Beyond the preview
Go deeper on Karo Healthcare AB.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Karo Healthcare AB.